Previous Article | Next Article 
Journal of Clinical Microbiology, August 2001, p. 2864-2872, Vol. 39, No. 8
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.8.2864-2872.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Characterization of Clinical Isolates of
Klebsiella pneumoniae from 19 Laboratories Using the
National Committee for Clinical Laboratory Standards
Extended-Spectrum
-Lactamase Detection Methods
Christine D.
Steward,1
J. Kamile
Rasheed,1
Susannah K.
Hubert,2
James W.
Biddle,1
Patti M.
Raney,2
Gregory J.
Anderson,1
Portia P.
Williams,2
Kelley L.
Brittain,2
Antonio
Oliver,3
John E.
McGowan Jr.,2 and
Fred C.
Tenover1,*
Division of Healthcare Quality Promotion,
Centers for Disease Control and Prevention, Atlanta, Georgia
30333,1 and Rollins School of Public
Health, Emory University, Atlanta, Georgia
30322,2 and Servicio de
Microbiología, Hospital Ramón y Cajal, 28034 Madrid,
Spain3
Received 20 November 2000/Returned for modification 6 February
2001/Accepted 7 June 2001
Extended-spectrum
-lactamases (ESBLs) are enzymes found in
gram-negative bacilli that mediate resistance to extended-spectrum cephalosporins and aztreonam. In 1999, the National Committee for
Clinical Laboratory Standards (NCCLS) published methods for screening
and confirming the presence of ESBLs in Klebsiella pneumoniae, Klebsiella oxytoca, and Escherichia coli. To evaluate
the confirmation protocol, we tested 139 isolates of K. pneumoniae that were sent to Project ICARE (Intensive Care
Antimicrobial Resistance Epidemiology) from 19 hospitals in 11 U.S.
states. Each isolate met the NCCLS screening criteria for potential
ESBL producers (ceftazidime [CAZ] or cefotaxime [CTX] MICs were
2
µg/ml for all isolates). Initially, 117 (84%) isolates demonstrated
a clavulanic acid (CA) effect by disk diffusion (i.e., an increase in
CAZ or CTX zone diameters of
5 mm in the presence of CA), and 114 (82%) demonstrated a CA effect by broth microdilution (reduction of
CAZ or CTX MICs by
3 dilutions). For five isolates, a CA effect could
not be determined initially by broth microdilution because of off-scale CAZ results. However, a CA effect was observed in two of these isolates
by testing cefepime and cefepime plus CA. The cefoxitin MICs for 23 isolates that failed to show a CA effect by broth microdilution were
32 µg/ml, suggesting either the presence of an AmpC-type
-lactamase or porin changes that could mask a CA effect. By
isoelectric focusing (IEF), 7 of the 23 isolates contained a
-lactamase with a pI of
8.3 suggestive of an AmpC-type
-lactamase; 6 of the 7 isolates were shown by PCR to contain both
ampC-type and blaOXA genes. The IEF
profiles of the remaining 16 isolates showed a variety of
-lactamase
bands, all of which had pIs of
7.5. All 16 isolates were negative by
PCR with multiple primer sets for ampC-type,
blaOXA, and blaCTX-M
genes. In summary, 83.5% of the K. pneumoniae isolates
that were identified initially as presumptive ESBL producers were
positive for a CA effect, while 5.0% contained
-lactamases that
likely masked the CA effect. The remaining 11.5% of the isolates
studied contained
-lactamases that did not demonstrate a CA effect.
An algorithm based on phenotypic analyses is suggested for evaluation
of such isolates.
*
Corresponding author. Mailing address: Division of
Healthcare Quality Promotion (G08), Centers for Disease Control and
Prevention, 1600 Clifton Rd., NE, Atlanta, GA 30333. Phone: (404)
639-3375. Fax: (404) 639-1381. E-mail: fnt1{at}cdc.gov.
Journal of Clinical Microbiology, August 2001, p. 2864-2872, Vol. 39, No. 8
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.8.2864-2872.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Fisher, M. A., Stamper, P. D., Hujer, K. M., Love, Z., Croft, A., Cohen, S., Bonomo, R. A., Carroll, K. C., Petti, C. A.
(2009). Performance of the Phoenix bacterial identification system compared with disc diffusion methods for identifying extended-spectrum {beta}-lactamase, AmpC and KPC producers. J Med Microbiol
58: 774-778
[Abstract]
[Full Text]
-
Leavitt, A., Chmelnitsky, I., Colodner, R., Ofek, I., Carmeli, Y., Navon-Venezia, S.
(2009). Ertapenem Resistance among Extended-Spectrum-{beta}-Lactamase-Producing Klebsiella pneumoniae Isolates. J. Clin. Microbiol.
47: 969-974
[Abstract]
[Full Text]
-
Literacka, E., Bedenic, B., Baraniak, A., Fiett, J., Tonkic, M., Jajic-Bencic, I., Gniadkowski, M.
(2009). blaCTX-M Genes in Escherichia coli Strains from Croatian Hospitals Are Located in New (blaCTX-M-3a) and Widely Spread (blaCTX-M-3a and blaCTX-M-15) Genetic Structures. Antimicrob. Agents Chemother.
53: 1630-1635
[Abstract]
[Full Text]
-
Tenover, F. C., Emery, S. L., Spiegel, C. A., Bradford, P. A., Eells, S., Endimiani, A., Bonomo, R. A., McGowan, J. E. Jr.
(2009). Identification of Plasmid-Mediated AmpC {beta}-Lactamases in Escherichia coli, Klebsiella spp., and Proteus Species Can Potentially Improve Reporting of Cephalosporin Susceptibility Testing Results. J. Clin. Microbiol.
47: 294-299
[Abstract]
[Full Text]
-
Jacoby, G. A.
(2009). AmpC {beta}-Lactamases. Clin. Microbiol. Rev.
22: 161-182
[Abstract]
[Full Text]
-
Navon-Venezia, S., Chmelnitsky, I., Leavitt, A., Carmeli, Y.
(2008). Dissemination of the CTX-M-25 family {beta}-lactamases among Klebsiella pneumoniae, Escherichia coli and Enterobacter cloacae and identification of the novel enzyme CTX-M-41 in Proteus mirabilis in Israel. J Antimicrob Chemother
62: 289-295
[Abstract]
[Full Text]
-
Baudry, P. J., Nichol, K., DeCorby, M., Mataseje, L., Mulvey, M. R., Hoban, D. J., Zhanel, G. G.
(2008). Comparison of Antimicrobial Resistance Profiles among Extended-Spectrum-{beta}-Lactamase-Producing and Acquired AmpC {beta}-Lactamase-Producing Escherichia coli Isolates from Canadian Intensive Care Units. Antimicrob. Agents Chemother.
52: 1846-1849
[Abstract]
[Full Text]
-
Mazzariol, A., Roelofsen, E., Koncan, R., Voss, A., Cornaglia, G.
(2007). Detection of a New SHV-Type Extended-Spectrum {beta}-Lactamase, SHV-31, in a Klebsiella pneumoniae Strain Causing a Large Nosocomial Outbreak in The Netherlands. Antimicrob. Agents Chemother.
51: 1082-1084
[Abstract]
[Full Text]
-
Tofteland, S., Haldorsen, B., Dahl, K. H., Simonsen, G. S., Steinbakk, M., Walsh, T. R., Sundsfjord, A., the Norwegian ESBL Study Group,
(2007). Effects of Phenotype and Genotype on Methods for Detection of Extended-Spectrum-{beta}-Lactamase-Producing Clinical Isolates of Escherichia coli and Klebsiella pneumoniae in Norway. J. Clin. Microbiol.
45: 199-205
[Abstract]
[Full Text]
-
Spanu, T., Sanguinetti, M., Tumbarello, M., D'Inzeo, T., Fiori, B., Posteraro, B., Santangelo, R., Cauda, R., Fadda, G.
(2006). Evaluation of the New VITEK 2 Extended-Spectrum Beta-Lactamase (ESBL) Test for Rapid Detection of ESBL Production in Enterobacteriaceae Isolates. J. Clin. Microbiol.
44: 3257-3262
[Abstract]
[Full Text]
-
Oteo, J., Navarro, C., Cercenado, E., Delgado-Iribarren, A., Wilhelmi, I., Orden, B., Garcia, C., Miguelanez, S., Perez-Vazquez, M., Garcia-Cobos, S., Aracil, B., Bautista, V., Campos, J.
(2006). Spread of Escherichia coli Strains with High-Level Cefotaxime and Ceftazidime Resistance between the Community, Long-Term Care Facilities, and Hospital Institutions. J. Clin. Microbiol.
44: 2359-2366
[Abstract]
[Full Text]
-
Chmelnitsky, I., Carmeli, Y., Leavitt, A., Schwaber, M. J., Navon-Venezia, S.
(2005). CTX-M-2 and a New CTX-M-39 Enzyme Are the Major Extended-Spectrum Beta-Lactamases in Multiple Escherichia coli Clones Isolated in Tel Aviv, Israel. Antimicrob. Agents Chemother.
49: 4745-4750
[Abstract]
[Full Text]
-
Paterson, D. L., Bonomo, R. A.
(2005). Extended-Spectrum {beta}-Lactamases: a Clinical Update. Clin. Microbiol. Rev.
18: 657-686
[Abstract]
[Full Text]
-
Song, W., Moland, E. S., Hanson, N. D., Lewis, J. S., Jorgensen, J. H., Thomson, K. S.
(2005). Failure of Cefepime Therapy in Treatment of Klebsiella pneumoniae Bacteremia. J. Clin. Microbiol.
43: 4891-4894
[Abstract]
[Full Text]
-
Coudron, P. E.
(2005). Inhibitor-Based Methods for Detection of Plasmid-Mediated AmpC {beta}-Lactamases in Klebsiella spp., Escherichia coli, and Proteus mirabilis. J. Clin. Microbiol.
43: 4163-4167
[Abstract]
[Full Text]
-
Kang, C.-I., Kim, S.-H., Park, W. B., Lee, K.-D., Kim, H.-B., Kim, E.-C., Oh, M.-D., Choe, K.-W.
(2004). Bloodstream Infections Due to Extended-Spectrum {beta}-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae: Risk Factors for Mortality and Treatment Outcome, with Special Emphasis on Antimicrobial Therapy. Antimicrob. Agents Chemother.
48: 4574-4581
[Abstract]
[Full Text]
-
Sturenburg, E., Lang, M., Horstkotte, M. A., Laufs, R., Mack, D.
(2004). Evaluation of the MicroScan ESBL plus confirmation panel for detection of extended-spectrum {beta}-lactamases in clinical isolates of oxyimino-cephalosporin-resistant Gram-negative bacteria. J Antimicrob Chemother
54: 870-875
[Abstract]
[Full Text]
-
Pai, H., Kang, C.-I., Byeon, J.-H., Lee, K.-D., Park, W. B., Kim, H.-B., Kim, E.-C., Oh, M.-d., Choe, K.-W.
(2004). Epidemiology and Clinical Features of Bloodstream Infections Caused by AmpC-Type-{beta}-Lactamase-Producing Klebsiella pneumoniae. Antimicrob. Agents Chemother.
48: 3720-3728
[Abstract]
[Full Text]
-
Saenz, Y., Brinas, L., Dominguez, E., Ruiz, J., Zarazaga, M., Vila, J., Torres, C.
(2004). Mechanisms of Resistance in Multiple-Antibiotic-Resistant Escherichia coli Strains of Human, Animal, and Food Origins. Antimicrob. Agents Chemother.
48: 3996-4001
[Abstract]
[Full Text]
-
Kaye, K. S., Gold, H. S., Schwaber, M. J., Venkataraman, L., Qi, Y., De Girolami, P. C., Samore, M. H., Anderson, G., Rasheed, J. K., Tenover, F. C.
(2004). Variety of {beta}-Lactamases Produced by Amoxicillin-Clavulanate-Resistant Escherichia coli Isolated in the Northeastern United States. Antimicrob. Agents Chemother.
48: 1520-1525
[Abstract]
[Full Text]
-
Schwaber, M. J., Raney, P. M., Rasheed, J. K., Biddle, J. W., Williams, P., McGowan, J. E. Jr., Tenover, F. C.
(2004). Utility of NCCLS Guidelines for Identifying Extended-Spectrum {beta}-Lactamases in Non-Escherichia coli and Non-Klebsiella spp. of Enterobacteriaceae. J. Clin. Microbiol.
42: 294-298
[Abstract]
[Full Text]
-
Lee, K., Lim, Y. S., Yong, D., Yum, J. H., Chong, Y.
(2003). Evaluation of the Hodge Test and the Imipenem-EDTA Double-Disk Synergy Test for Differentiating Metallo-{beta}-Lactamase-Producing Isolates of Pseudomonas spp. and Acinetobacter spp.. J. Clin. Microbiol.
41: 4623-4629
[Abstract]
[Full Text]
-
Rodriguez-Martinez, J. M., Pascual, A., Garcia, I., Martinez-Martinez, L.
(2003). Detection of the plasmid-mediated quinolone resistance determinant qnr among clinical isolates of Klebsiella pneumoniae producing AmpC-type {beta}-lactamase. J Antimicrob Chemother
52: 703-706
[Abstract]
[Full Text]
-
van Westreenen, M., Paauw, A., Fluit, A. C., Brisse, S., van Dijk, W., Verhoef, J.
(2003). Occurrence and spread of SHV extended-spectrum {beta}-lactamase-producing Klebsiella pneumoniae isolates in Curacao. J Antimicrob Chemother
52: 530-532
[Full Text]
-
Tenover, F. C., Raney, P. M., Williams, P. P., Rasheed, J. K., Biddle, J. W., Oliver, A., Fridkin, S. K., Jevitt, L., McGowan, J. E. Jr.
(2003). Evaluation of the NCCLS Extended-Spectrum {beta}-Lactamase Confirmation Methods for Escherichia coli with Isolates Collected during Project ICARE. J. Clin. Microbiol.
41: 3142-3146
[Abstract]
[Full Text]
-
Sanguinetti, M., Posteraro, B., Spanu, T., Ciccaglione, D., Romano, L., Fiori, B., Nicoletti, G., Zanetti, S., Fadda, G.
(2003). Characterization of Clinical Isolates of Enterobacteriaceae from Italy by the BD Phoenix Extended-Spectrum {beta}-Lactamase Detection Method. J. Clin. Microbiol.
41: 1463-1468
[Abstract]
[Full Text]
-
Yamasaki, K., Komatsu, M., Yamashita, T., Shimakawa, K., Ura, T., Nishio, H., Satoh, K., Washidu, R., Kinoshita, S., Aihara, M.
(2003). Production of CTX-M-3 extended-spectrum {beta}-lactamase and IMP-1 metallo {beta}-lactamase by five Gram-negative bacilli: survey of clinical isolates from seven laboratories collected in 1998 and 2000, in the Kinki region of Japan. J Antimicrob Chemother
51: 631-638
[Abstract]
[Full Text]
-
Coudron, P. E., Hanson, N. D., Climo, M. W.
(2003). Occurrence of Extended-Spectrum and AmpC Beta-Lactamases in Bloodstream Isolates of Klebsiella pneumoniae: Isolates Harbor Plasmid-Mediated FOX-5 and ACT-1 AmpC Beta-Lactamases. J. Clin. Microbiol.
41: 772-777
[Abstract]
[Full Text]
-
Oliver, A., Weigel, L. M., Rasheed, J. K., McGowan, J. E. Jr., Raney, P., Tenover, F. C.
(2002). Mechanisms of Decreased Susceptibility to Cefpodoxime in Escherichia coli. Antimicrob. Agents Chemother.
46: 3829-3836
[Abstract]
[Full Text]
-
Brinas, L., Zarazaga, M., Saenz, Y., Ruiz-Larrea, F., Torres, C.
(2002). {beta}-Lactamases in Ampicillin-Resistant Escherichia coli Isolates from Foods, Humans, and Healthy Animals. Antimicrob. Agents Chemother.
46: 3156-3163
[Abstract]
[Full Text]
-
Hujer, A. M., Page, M. G. P., Helfand, M. S., Yeiser, B., Bonomo, R. A.
(2002). Development of a Sensitive and Specific Enzyme-Linked Immunosorbent Assay for Detecting and Quantifying CMY-2 and SHV {beta}-Lactamases. J. Clin. Microbiol.
40: 1947-1957
[Abstract]
[Full Text]